Related Experiment Videos

Neurosyphilis: how do you know, and what do you do?

Keith Henry, Joseph I Harwell

AIDS Clinical Care

|May 27, 2003

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Childhood Antimicrobial Resistance With Global Forecasts.

JAMA pediatrics·2026

Efficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase 3 randomized, double-blind, multicenter, active-controlled, non-inferiority study.

Medicine·2025

Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.

NEJM evidence·2023

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.

The lancet. HIV·2021

Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria.

AIDS (London, England)·2021

Association of in utero antibiotic exposure on childhood ear infection trajectories: Results from a national birth cohort study.

Journal of paediatrics and child health·2021

See all related articles